An Addition to the Oncotype DX Family

May 15, 2009

The Wall Street Journal reports that Genomic Health has developed the Oncotype DX colon-cancer test, a genetic screen "that can predict whether patients treated for early-stage colon cancer are likely to suffer a recurrence of the disease," according to the story. A validation study of the test was presented in advance of the American Society of Clinical Oncology annual meeting.

Breaking News

Vibrent Health, University of Maryland Medicine Partner for Population Health Initiative
Polygenic Risk Scores for Breast, Prostate Cancer Adaptable for Cross-Ancestry Use, Study Shows
Molecular Clonal Tracking Method Captures Lung Cancer Treatment Response, Resistance Features
Oxford Nanopore Technologies to Raise £300M in IPO, Including £150M Investment by Oracle
Thermo Fisher Scientific Receives CE Mark for TaqPath COVID-19 RNase P 2.0 Testing Kit
Castle Biosciences Receives New York State Approval for DecisionDx DiffDx-Melanoma Test

The Scan

Tennessee's COVID-19 Sequencing

The Tennessean reports that a state lab there can now run its own genome sequencing analyses of SARS-CoV-2 samples.

Sanction Violation Charges

A former professor has been charged with exporting genetic sequencing equipment to Iran in violation of US sanctions, the Miami Herald reports.

Prenetics to Go Public Through SPAC

Prenetics, a Hong Kong-based genomic and diagnostic company, is going public through a SPAC merger, according to 360Dx.

Nature Papers Examine Genomes of Centenarians, Transcription-Coupled DNA Repair

In Nature this week: analysis of centenarian genomes uncovers longevity-linked variants, and more.

An Addition to the Oncotype DX Family

Vibrent Health, University of Maryland Medicine Partner for Population Health Initiative

Polygenic Risk Scores for Breast, Prostate Cancer Adaptable for Cross-Ancestry Use, Study Shows

Molecular Clonal Tracking Method Captures Lung Cancer Treatment Response, Resistance Features

Oxford Nanopore Technologies to Raise £300M in IPO, Including £150M Investment by Oracle

Thermo Fisher Scientific Receives CE Mark for TaqPath COVID-19 RNase P 2.0 Testing Kit

Castle Biosciences Receives New York State Approval for DecisionDx DiffDx-Melanoma Test

Tennessee's COVID-19 Sequencing

Sanction Violation Charges

Prenetics to Go Public Through SPAC

Nature Papers Examine Genomes of Centenarians, Transcription-Coupled DNA Repair

Illumina Adds Seven Genomics Startups to Accelerator Program

Exact Sciences Stock Spikes After Primary Care Sales Team Nearly Doubles

Ginkgo Bioworks to Go Public With $1.63B in Proceeds From SPAC Merger

Oxford Nanopore Technologies Registers for IPO on London Stock Exchange

Centenarian Exome Analysis Points to Conserved Longevity Pathways